The Oncology Institute, Inc. TOI Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $545.76M+8.6% | $502.73M+9.0% | $461.04M+8.6% | $424.38M+5.3% | $403.15M+2.5% | ||
| $108.41M+2.7% | $105.57M+3.1% | $102.39M-1.3% | $103.79M-0.9% | $104.75M-2.9% | ||
| $6.78M-2.4% | $6.94M-1.1% | $7.02M+2.2% | $6.87M+4.4% | $6.58M+4.7% | ||
| $578.45M+7.4% | $538.81M+7.3% | $502.14M+6.5% | $471.28M+3.5% | $455.21M+0.4% | ||
| -$32.69M+9.4% | -$36.08M+12.2% | -$41.11M+12.4% | -$46.9M+9.9% | -$52.06M+13.4% | ||
| -6%+1.2pp | -7.2%+1.7pp | -8.9%+2.1pp | -11.1%+1.9pp | -12.9%+2.4pp | ||
| $7.64M-32.2% | $11.28M+7.1% | $10.53M-2.8% | $10.83M-2.2% | $11.08M+47.8% | ||
| -$10.96M+55.5% | -$24.65M+2.6% | -$25.31M-32.4% | -$19.12M-55.4% | -$12.3M-171% | ||
| -$43.64M+28.1% | -$60.74M+8.5% | -$66.41M-0.6% | -$66.02M-2.6% | -$64.36M+0.5% | ||
| -$131K0.0% | -$131K0.0% | -$131K0.0% | -$131K— | $0— | ||
| -$43.51M+28.2% | -$60.61M+8.6% | -$66.28M-0.6% | -$65.89M-2.4% | -$64.36M+0.5% | ||
| -8%+4.1pp | -12.1%+2.3pp | -14.4%+1.1pp | -15.5%+0.4pp | -16%+0.5pp | ||
| -$0.36+34.5% | -$0.55+15.4% | -$0.65+5.8% | -$0.69+2.8% | -$0.71+1.4% | ||
| -$0.36+34.5% | -$0.55+15.4% | -$0.65+5.8% | -$0.69+2.8% | -$0.71+1.4% | ||
| 384.9M+6.9% | 360.2M+5.1% | 342.8M+6.8% | 320.9M+6.1% | 302.4M+1.0% | ||
| 384.9M+6.9% | 360.2M+5.1% | 342.8M+6.8% | 320.9M+6.1% | 302.4M+1.0% | ||
| -$4.97M+62.6% | -$13.27M-1.0% | -$13.14M-83.4% | -$7.17M-1,071% | -$612K-123% | ||
| —— | —— | -$1.44M-32.0% | -$1.09M+8.3% | -$1.19M-225% | ||
| $545.76M+8.6% | $502.73M+9.0% | $461.04M+8.6% | $424.38M+5.3% | $403.15M+2.5% | ||
| -$32.69M+9.4% | -$36.08M+12.2% | -$41.11M+12.4% | -$46.9M+9.9% | -$52.06M+13.4% | ||
| -$25.91M+11.1% | -$29.14M+14.5% | -$34.09M+14.9% | -$40.04M+12.0% | -$45.48M+15.5% | ||
| -$25.91M+11.1% | -$29.14M+14.5% | -$34.09M+14.9% | -$40.04M+12.0% | -$45.48M+15.5% | ||
| -4.7%+1.0pp | -5.8%+1.6pp | -7.4%+2.0pp | -9.4%+1.8pp | -11.3%+2.4pp | ||
| -$32.69M+9.4% | -$36.08M+12.2% | -$41.11M+12.4% | -$46.9M+9.9% | -$52.06M+13.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is The Oncology Institute, Inc.'s revenue?
- The Oncology Institute, Inc. (TOI) generated $545.8M in revenue over the trailing twelve months, up 35.4% year over year.
- Is The Oncology Institute, Inc. profitable?
- The Oncology Institute, Inc. is not currently profitable: it reported a net loss of $43.5M over the trailing twelve months, a -8.0% net margin.
- What is The Oncology Institute, Inc.'s earnings per share?
- The Oncology Institute, Inc.'s diluted EPS over the trailing twelve months is $-0.36.
- Where does The Oncology Institute, Inc.'s income statement data come from?
- Every line is extracted from The Oncology Institute, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
